Skip to main content Accessibility Statement

Investors

At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders

--

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Upcoming Events

More events are coming soon.

Recent News

  • September 16, 2024

    Tactile Medical Receives PDAC Approval for Nimbl™ Lymphedema Platform

    Next-Generation System Significantly Reduces Device Size and Weight and Enables Integration with Kylee™ Digital App MINNEAPOLIS , Sept. 16, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies

    Read more

  • August 5, 2024

    Tactile Systems Technology, Inc. Reports Second Quarter 2024 Financial Results

    MINNEAPOLIS , Aug. 05, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the second quarter ended June 30, 2024 .

    Read more

  • July 22, 2024

    Tactile Medical to Release Second Quarter of Fiscal Year 2024 Financial Results on August 5, 2024

    MINNEAPOLIS , July 22, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that second quarter of fiscal year 2024 financial results will be

    Read more